Le Lézard
Classified in: Health
Subjects: CCA, PET

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement


GREENFIELD, Ind., Feb. 8, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2023 financial results on Monday, February 26, 2024. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.

The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website on our events and presentations page. A replay will also be available on the website shortly following the call.

ABOUT ELANCO 

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose? all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com

Investor Contact: Katy Grissom +1.317.273.9284 [email protected]
Media Contact: Colleen Parr Dekker +1.317.989.7011 [email protected]

SOURCE Elanco Animal Health


These press releases may also interest you

at 09:15
IPG Health Unlocks Next-Gen Data, AI & Tech-Enabled Platforms for Healthcare
In the sea of content today, customers ? HCPs and consumers alike ? are overwhelmed with information. This content might be reaching them, but not effectively resonating and activating them to change behaviors. Cutting through this noise requires...

at 09:15
NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List
NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targeting the novel B7-H7/HHLA2 axis, announced today that Chief Executive Officer Ivan Cheung has been...

at 09:10
New Data Validating the First AI-Based Biomarker to Stratify Risk of Metastasis in Radical Prostatectomy Patients with Biochemical Recurrence
ArteraAI, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the validation of its first multimodal artificial intelligence (MMAI) digital pathology-based post-radical prostatectomy biomarker...

at 09:08
Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park
Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company's latest investment to expand its analytical testing services supporting life...

at 09:07
PLANET FITNESS CONTINUES EXPANSION INTO ST. LOUIS METRO
Midwest Fitness Partners (MFP), one of the largest and fastest-growing Planet Fitness franchisees announced they have four new units in development in the St. Louis metro area. The first, a 30,000 square foot unit located at the Gravois Bluffs...

at 09:05
Seasoned Industry Leader Peter Martis Appointed at ID R&D to Drive Explosive Growth Initiatives
ID R&D, a Mitek Systems company, and the leading provider of AI-driven biometric solutions, proudly announced the appointment of Peter Martis as Vice President of Growth. Respected as a thought leader in biometric technology and renowned for his...

More news about Health...


News published on and distributed by: